Institutional shares held 88.3 Million
0 calls
0 puts
Total value of holdings $37.1M
$0 calls
$0 puts
Market Cap $35M
83,277,504 Shares Out.
Institutional ownership 106.04%
# of Institutions 62


Latest Institutional Activity in OPTN

Top Purchases

Q3 2024
Stonepine Capital Management, LLC Shares Held: 5.69M ($2.39M)
Q3 2024
Nantahala Capital Management, LLC Shares Held: 14.4M ($6.03M)
Q3 2024
J. Goldman & CO LP Shares Held: 675K ($284K)
Q3 2024
Prescott Group Capital Management, L.L.C. Shares Held: 1.25M ($526K)
Q3 2024
Geode Capital Management, LLC Shares Held: 1.3M ($545K)

Top Sells

Q3 2024
Great Point Partners LLC Shares Held: 12.9M ($5.4M)
Q3 2024
Millennium Management LLC Shares Held: 629K ($264K)
Q3 2024
Northern Trust Corp Shares Held: 254K ($106K)
Q3 2024
Velan Capital Investment Management LP Shares Held: 2.15M ($902K)
Q3 2024
Jane Street Group, LLC Shares Held: 42.3K ($17.8K)

About OPTN

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.


Insider Transactions at OPTN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.61M Shares
From 5 Insiders
Grant, award, or other acquisition 1.61M shares
Sell / Disposition
299K Shares
From 3 Insiders
Open market or private sale 299K shares

Track Institutional and Insider Activities on OPTN

Follow OptiNose, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPTN shares.

Notify only if

Insider Trading

Get notified when an Opti Nose, Inc. insider buys or sells OPTN shares.

Notify only if

News

Receive news related to OptiNose, Inc.

Track Activities on OPTN